Iveta Kudaba

12.7k citations
24 papers · 750 · 1 hit paper · h-index 14

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 11
    • Lung Cancer Research Studies 5
    • Colorectal Cancer Treatments and Studies 3
    • Lung Cancer Treatments and Mutations 6
    • Gastric Cancer Management and Outcomes 6
    • Lung Cancer Diagnosis and Treatment 3

Iveta Kudaba

23 papers receiving 739 citations

Iveta Kudaba's Hit Papers

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study 2022 · 151 citations
1510+1+2Years since publication50100150

Peers

Iveta Kudaba
Comparison fields: 5 of 52
  • Oncology 635
  • Gastroenterology 87
  • Pulmonary and Respiratory Medicine 490
  • Cancer Research 72
  • Immunology 75
Replace Takashi Ichimura with:
Takashi Ichimura Japan
Ellie Corigliano United States
Eduardo Yañez Ruiz United States
André L. Montagnini Brazil
Matías Chacón Argentina
Salah-Eddin Al-Batran Germany
Jong Inn Lee South Korea
Claire Saffery United Kingdom
Daniel Virgil Thomas Catenacci United States
Joanna Huszno Poland
Iveta Kudaba relative to Takashi Ichimura Japan Takashi Ichimura's profile →
Citations per field
00.5×1.5×2.1×
Takashi Ichimura · 1×
Citations per year

Countries citing papers authored by Iveta Kudaba

Since Specialization
Citations

This map shows the geographic impact of Iveta Kudaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iveta Kudaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iveta Kudaba more than expected).

Fields of papers citing papers by Iveta Kudaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iveta Kudaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iveta Kudaba. The network helps show where Iveta Kudaba may publish in the future.

Co-authors

The 25 scholars most cited alongside Iveta Kudaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iveta Kudaba Line = papers co-authored together Iveta Kudaba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Hit paper breakdown →
2022151
2 2018138
3 2019131
4 202059
5 202255
6 201932
7 201922
8 202120
9 201319
10 201818
11 200518
12 202217
13 201916
14 202115
15 202112
16 202011
17 20196
18 20193
19 20122
20 20111

About Iveta Kudaba

Iveta Kudaba is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Epidemiology, having authored 24 papers that have together received 750 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (6 papers), Gastric Cancer Management and Outcomes (6 papers), Lung Cancer Research Studies (5 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (635 citations), Gastroenterology (87 citations), Pulmonary and Respiratory Medicine (490 citations), Cancer Research (72 citations) and Immunology (75 citations). Iveta Kudaba has collaborated with scholars based in Latvia, United States and Japan. Frequent co-authors include Igor Bondarenko, Byoung Chul Cho, Vichien Srimuninnimit, Dariusz M. Kowalski, Gilberto de Castro, Tony Mok, Yi‐Long Wu, Kohei Shitara, Zev A. Wainberg and Marcelo Garrido. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, International Journal of Cancer and Molecular Imaging and Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact